Threonine and lysine markets have become active in some regions, notably Europe, where buyers concluded contracts for the rest of Q2 and part of Q3. Tryptophan and methionine markets are weak, and Valine ex China continues to see delays.
Contracting by feed buyers at low prices supports near-term lysine and threonine values, though ample availability limits upside; weak methionine and tryptophan point to softer pressure on those amino acids.
Not enough comparable past events yet for a historical read.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.